References
- S Broder, and RC Gallo. (1984). A pathogenic retrovirus (HTLV-III) linked to AIDS. N Engl J Med 311:1292–1297.
- http:www.unaids.org.
- DL Bowen, HC Hane, and AC Fauci. (1985). Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med 163:704–709.
- C Dye, S Scheele, P Dolin, V Pathania, and MC Raviglione. (1999). Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677–686.
- PA Selwyn, D Hartel, W Wasserman, and E Drucker. (1989). Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 79:1358–1362.
- CL Daley, PM Small, and GF Schecter. (1992). An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 326:231–235.
- D Sriram, and P Yogeeswari. (2003). Towards the design and development of agents with broad spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Curr Med Chem 10:1689–1695.
- D Sriram, TR Bal, and P Yogeeswari. (2004). Design, synthesis and biological evaluation of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. Bioorg Chem 12:5865–5873.
- D Sriram, P Yogeeeswari, N Srichakravarthy, and TR Bal. (2004). Synthesis of stavudine amino acid ester prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Bioorg Med Chem Lett 14:1085–1087.
- D Sriram, P Yogeeswari, and G Gopal. (2005). Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs. Eur J Med Chem 40:1373–1376.
- D Sriram, N Srichakravarthy, TR Bal, and P Yogeeswari. (2005). Synthesis of zidovudine prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Biomed Pharmacother 59:452–455.
- D Sriram, N Srichakravarthy, TR Bal, and P Yogeeswari. (2005). Nevirapine derivatives with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Biomed Pharmacother 59:456–459.
- D Sriram, P Yogeeswari, NS Myneedu, and V Saraswat. (2006). Abacavir prodrugs: microwave-assisted synthesis and their evaluation of anti-HIV activities. Bioorg Med Chem 16:2127–2129.
- D Sriram, TR Bal, and P Yogeeswari. (2005). Aminopyrimidinimino isatin analogues: design of novel non- nucleoside HIV-1 reverse transcriptase inhibitors with broad-spectrum chemotherapeutic properties. Med Chem 20:565–577.
- National Committee for Clinical Laboratory Standards. Antimycobacterial susceptibility testing. Proposed standard M24-P. Villanova, Pa: National Committee for Clinical Laboratory Standards; (1990).
- SK Agarwal, SR Gogu, SRS Rangan, and KC Agrawal. (1990). Synthesis and biological evaluation of prodrugs of zidovudine. J Med Chem 33:1505–1509.
- SD Young, SF Britcher, LO Tran, LS Payne, WC Lumma, TA Lyle, JR Huff, PS Anderson, DB Olsenn, SS Carroll, DJ Pettibone, JA O'Brien, RG Ball, SK Balani, JH Lin, IW Chen, WA Schleif, VV Sardana, WJ Long, VW Brynes, and EA Emini. (1995). L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 39:2602–2605.
- M Patel, SS Ko, RJ McHugh, JA Markwalder, AS Srivastava, BC Cordova, RM Klabe, S Erickson-Viitanen, GL Trainor, and SP Seit. (1999). Synthesis and evaluation of analogs of Efavirenz (SUSTIVA) as HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem Lett 9:2805–2810.
- P Yogeeswari, D Sriram, R Kavya, and S Tiwari. (2005). Synthesis and in-vitro cytotoxicity evaluation of gatifloxacin Mannich bases. Biomed Pharmacother 59:501–510.
- D Sriram, P Yogeeswari, SJ Basha, D Radha, and V Nagaraja. (2005). Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives. Bioorg Med Chem 13:5774–5778.